PFE
16
2
EA
63
3
DUK
52
2
AAPL
45
6
PLD
48
3
VLO
45
5
APD
57
5
WBA
45
2
AIG
44
2
AEE
60
2
SEE
45
-8
V
66
2
KO
41
3
HSY
29
-2
ADP
64
2
DGX
50
2
TRV
58
2
FSLR
46
2
ICE
62
3
PPL
52
2
PFE
16
2
EA
63
3
DUK
52
2
AAPL
45
6
PLD
48
3
VLO
45
5
APD
57
5
WBA
45
2
AIG
44
2
AEE
60
2
SEE
45
-8
V
66
2
KO
41
3
HSY
29
-2
ADP
64
2
DGX
50
2
TRV
58
2
FSLR
46
2
ICE
62
3
PPL
52
2
Financhill
Back

Harbor Multi-Asset Explorer ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
97

MAPP
Harbor Multi-Asset Explorer ETF

Last Price:
23.83
Seasonality Move:
6.08%
Sell
35

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Buy
97
Harbor Multi-Asset Explorer ETF (MAPP) is a Buy

Is Harbor Multi-Asset Explorer ETF a Buy, Sell or Hold?

  • The current Harbor Multi-Asset Explorer ETF [MAPP] share price is $23.83. The Score for MAPP is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
  • MAPP is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
35
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MAPP Stock Price Chart

What is Harbor Multi-Asset Explorer ETF's stock price today?

  • The Harbor Multi-Asset Explorer ETF share price today is $23.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAPP is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $42.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MAPP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 64.55 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.39 - 23.77) Buy
Bollinger Bands (100): (22.44 - 23.58) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 26.84 Sell
Chaikin Money Flow: -3822578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.96 - 58.72) Sell
Bollinger Bands (100): (51.86 - 60.48) Sell

MAPP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.81 Buy
20-day SMA: 23.58 Buy
50-day SMA: 23.47 Buy
200-day SMA: 22.29 Buy
8-day EMA: 23.77 Buy
20-day EMA: 23.65 Buy
50-day EMA: 23.42 Buy
200-day EMA: 22.27 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.27 Sell
20-day SMA: 54.02 Sell
50-day SMA: 55.85 Sell
200-day SMA: 48.97 Sell
8-day EMA: 52.24 Sell
20-day EMA: 54.19 Sell
50-day EMA: 55.13 Sell
200-day EMA: 50.65 Sell

Harbor Multi-Asset Explorer ETF Earnings Growth & MAPP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Harbor Multi-Asset Explorer ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):